Published in Am J Pathol on September 01, 1998
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res (2010) 2.50
The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J Cell Biol (2000) 1.40
KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma. Am J Pathol (2001) 1.14
Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. Am J Pathol (1999) 1.13
Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array. World J Gastroenterol (2002) 1.11
Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer (2003) 1.09
A novel therapeutic strategy with anti-CD9 antibody in gastric cancers. J Gastroenterol (2009) 1.01
Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. Br J Pharmacol (2014) 1.01
Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer. Clin Cancer Res (2010) 0.99
Effect of an anti-human Co-029/tspan8 mouse monoclonal antibody on tumor growth in a nude mouse model. Front Physiol (2014) 0.93
Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma. World J Surg Oncol (2011) 0.93
Uroplakin Ib gene transcription in urothelial tumor cells is regulated by CpG methylation. Neoplasia (2005) 0.93
Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approach. J Cancer Res Clin Oncol (2010) 0.93
KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers. Oncotarget (2015) 0.93
Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo. Mol Cancer (2014) 0.92
Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model. Magn Reson Imaging (2012) 0.89
RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy. Mol Cancer (2014) 0.88
CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma. BMC Clin Pathol (2009) 0.86
The tetraspanin superfamily member NET-6 is a new tumor suppressor gene. J Cancer Res Clin Oncol (2007) 0.86
Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors. J Biol Chem (2012) 0.84
KAI1 gene is differently expressed in papillary and pancreatic cancer: influence on metastasis. World J Gastroenterol (2000) 0.84
mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein. Oncoscience (2015) 0.81
Down-regulation of CD9 expression and its correlation to tumor progression in B lymphomas. Am J Pathol (2010) 0.81
The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization. J Cell Sci (2011) 0.81
Metastasis suppressor genes. Histol Histopathol (2013) 0.80
Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck. Br J Cancer (2004) 0.80
The role of SRC family kinases in prostate cancer. Transl Oncogenomics (2007) 0.80
Intravenous KITENIN shRNA injection suppresses hepatic metastasis and recurrence of colon cancer in an orthotopic mouse model. J Korean Med Sci (2011) 0.80
Novel CD9-targeted therapies in gastric cancer. World J Gastroenterol (2015) 0.79
Down-regulation of CD9 by methylation decreased bortezomib sensitivity in multiple myeloma. PLoS One (2014) 0.78
Tetraspanin protein KAI1 expression in retinoblastoma. Br J Ophthalmol (2004) 0.77
Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma. Oncol Lett (2015) 0.76
Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes. Oncotarget (2016) 0.75
Effects of KAI1 gene on growth and invasion of human hepatocellular carcinoma MHCC97-H cells. World J Gastroenterol (2004) 0.75
CD9 Expression in Colorectal Carcinomas and Its Prognostic Significance. J Pathol Transl Med (2016) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep (1966) 48.83
Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci U S A (1985) 4.80
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst (1993) 4.45
KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (1995) 3.97
TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol (1990) 2.60
Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res (1986) 2.37
CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol (1996) 2.10
The ins and outs of the transmembrane 4 superfamily. Immunol Today (1994) 2.00
The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J Exp Med (1989) 1.99
Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell (1996) 1.94
Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res (1988) 1.72
Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med (1993) 1.70
Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol (1996) 1.63
Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res (1996) 1.59
Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). J Immunol (1996) 1.54
Association of TM4SF proteins with integrins: relevance to cancer. Biochim Biophys Acta (1996) 1.51
Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res (1996) 1.50
Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics (1994) 1.46
Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc Natl Acad Sci U S A (1996) 1.45
Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res (1997) 1.39
Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med (1991) 1.34
Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res (1995) 1.28
Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg (1995) 1.24
Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int J Cancer (1995) 1.20
Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res (1995) 1.13
Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res (1996) 1.07
KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett (1997) 1.02
A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur J Immunol (1991) 1.01
TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Genes Chromosomes Cancer (1996) 1.00
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol. Cancer (1994) 0.95
Identification and analysis of cDNA clones encoding CD53. A pan-leukocyte antigen related to membrane transport proteins. J Immunol (1990) 0.90
MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues. Int J Oncol (1997) 0.89
Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Mol Carcinog (1998) 0.89
Rare spontaneously transformed human endothelial cell line provides useful research tool. In Vitro Cell Dev Biol (1992) 0.87
Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer. Anticancer Res (1994) 0.85
The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes. J Immunol (1997) 0.82
CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature (1997) 10.49
Lethal effect of the anti-Fas antibody in mice. Nature (1993) 9.20
A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol (2000) 5.46
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature (1998) 3.86
Downregulation of Fas ligand by shedding. Nat Med (1998) 3.83
Essential roles of the Fas ligand in the development of hepatitis. Nat Med (1997) 3.05
Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol (1990) 2.69
Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene (1993) 2.67
A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet (1999) 2.54
Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med (1992) 2.52
Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO J (2001) 2.50
Characterization and gene cloning of 1,3-beta-D-glucan synthase from Saccharomyces cerevisiae. Eur J Biochem (1995) 2.45
p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J (2000) 2.38
Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. Infect Control Hosp Epidemiol (1992) 2.37
A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med (1993) 2.29
PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol Cell Biol (1994) 2.27
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Force generation in the outer hair cell of the cochlea. Biophys J (1997) 2.01
Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells. Mol Gen Genet (1996) 2.00
Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J (1999) 1.97
Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-beta1 and aldosterone. Kidney Int (2006) 1.94
Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension (1998) 1.88
Ongoing prospective study of segmentectomy for small lung tumors. Study Group of Extended Segmentectomy for Small Lung Tumor. Ann Thorac Surg (1998) 1.83
Prenatal diagnosis of Tay-Sachs disease. Lancet (1970) 1.83
Small "flat adenoma" of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum (1985) 1.82
Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit. Mol Cell Biol (1998) 1.80
Relation of pancreatic duct hyperplasia to carcinoma. Cancer (1979) 1.78
The mouse and human homologs of DMC1, the yeast meiosis-specific homologous recombination gene, have a common unique form of exon-skipped transcript in meiosis. Nucleic Acids Res (1996) 1.75
Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer (1999) 1.72
Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain. Gene (1995) 1.71
Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J Allergy Clin Immunol (1996) 1.71
Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med (1993) 1.70
Peripheral ameloblastic fibroma of the mandible: report of a case. J Oral Maxillofac Surg (1998) 1.64
Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood (1997) 1.63
Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology (1997) 1.60
Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res (1996) 1.59
Clinical and neuroradiological features of intracranial vertebrobasilar artery dissection. Stroke (1999) 1.59
Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol (2002) 1.58
Altered cellular responses by varying expression of a ribosomal protein gene: sequential coordination of enhancement and suppression of ribosomal protein S3a gene expression induces apoptosis. J Cell Biol (1998) 1.57
p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity. Oncogene (2007) 1.56
A novel regulatory mechanism in the mitogen-activated protein (MAP) kinase cascade. Role of nuclear export signal of MAP kinase kinase. J Biol Chem (1997) 1.55
Usefulness of contrast-enhanced endoscopic ultrasonography with intravenous injection of sonicated serum albumin. Gastrointest Endosc (1997) 1.54
Bmf is a possible mediator in histone deacetylase inhibitors FK228 and CBHA-induced apoptosis. Cell Death Differ (2006) 1.54
The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol Cell Biol (2001) 1.51
Distribution of Staphylococcus species among human clinical specimens and emended description of Staphylococcus caprae. J Clin Microbiol (1998) 1.51
Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax (2008) 1.51
Adoptive transfer of T-helper cell type 1 clones attenuates an asthmatic phenotype in mice. Eur Respir J (2005) 1.49
Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum Mol Genet (2001) 1.48
Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis. Genes Dev (2000) 1.47
Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol (1994) 1.47
4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain. Mol Pharmacol (1976) 1.46
Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma. Clin Exp Allergy (2007) 1.44
Spongy degeneration of the central nervous system (van Bogaert and Bertrand type; Canavan's disease). A review. Hum Pathol (1973) 1.42
Detection of chimeric mRNAs by reverse transcriptase-polymerase chain reaction for diagnosis and monitoring of acute leukemias with 11q23 abnormalities. Med Pediatr Oncol (1997) 1.41
Distal acinar emphysema and interstitial pneumonia in a patient with von Recklinghausen's disease: five-year observation following quitting smoking. Intern Med (1997) 1.41
Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention. Cardiovasc Drugs Ther (2001) 1.40
Osteoprotegerin and bone mineral density in hemodialysis patients. Osteoporos Int (2006) 1.39
A long-term survey of rotavirus infection in Japanese children with acute gastroenteritis. J Infect Dis (1978) 1.39
Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J Neurochem (1988) 1.39
Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1998) 1.39
Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells. Clin Exp Allergy (2006) 1.39
Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation (1997) 1.38
Erectile dysfunction is strongly linked with decreased libido in diabetic men. Aging Male (2004) 1.38
Idiopathic CD4+ T-lymphocytopenia with Bowen's disease. Intern Med (1997) 1.38
Near-death asthmatic reaction induced by disodium cromoglycate. Intern Med (1996) 1.38
Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Mol Cell Biol (1995) 1.38
IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol (1998) 1.37
Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion. Intern Med (2001) 1.37
A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia (2000) 1.36
Effect of outdoor and indoor nitrogen dioxide on respiratory symptoms in schoolchildren. Int J Epidemiol (2000) 1.36
[Late phase II study of S-1 in patients with advanced head and neck cancer]. Gan To Kagaku Ryoho (2001) 1.35
Development of nested PCR based on the ViaB sequence to detect Salmonella typhi. J Clin Microbiol (1995) 1.34
Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med (1995) 1.34
In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene. Biochem Biophys Res Commun (1998) 1.34
A comparison between Japanese-Americans living in Hawaii and Los Angeles and native Japanese: the impact of lifestyle westernization on diabetes mellitus. Biomed Pharmacother (2004) 1.34
Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells. Oncogene (1998) 1.33
Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. Cancer Res (1998) 1.33
Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax (2002) 1.32
CT appearance of pulmonary tuberculosis in diabetic and immunocompromised patients: comparison with patients who had no underlying disease. AJR Am J Roentgenol (1992) 1.31
Retroperitoneal ganglioneuroma: a case report and review of the Japanese literature. Intern Med (1992) 1.30
Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Clin Cancer Res (2000) 1.30
Neutrophilic airway inflammation and IL-17. Allergy (2002) 1.28
Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging. Eur J Nucl Med (1998) 1.28
A new method for purification of anti-glycosphingolipid antibody. Avian anti-hematoside (NeuGc) antibody. J Biochem (1983) 1.28
Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res (1995) 1.28
Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer (1998) 1.28
Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am J Respir Cell Mol Biol (1998) 1.28
Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene (1997) 1.27
A ubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors. Cell Growth Differ (1990) 1.27
Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proc Natl Acad Sci U S A (1994) 1.27
Expression of chemokines and induction of rapid cell death in human blood neutrophils by Mycobacterium tuberculosis. J Infect Dis (1998) 1.26
Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion. Cancer Res (1996) 1.26
Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol (2000) 1.25